Warby Parker (WRBY) Depreciation & Amortization (CF) (2020 - 2026)
Warby Parker's (WRBY) quarterly Depreciation & Amortization (CF) came in at $3.9 million in Q1 2026, up 12.81% YoY from $3.5 million in Q1 2025, and down 70.15% on a QoQ basis from $13.1 million in Q4 2025.
Warby Parker (WRBY) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 12.81% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.5 million (up 41.55% YoY) and the FY2025 annual result came in at $50.3 million, up 9.63% from the prior year.
- Depreciation & Amortization (CF) retreated to $3.9 million in Q1 2026, from $13.1 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $13.1 million in Q4 2025 to a low of $2.8 million in Q2 2022.
- A 5-year average of $7.6 million and a median of $7.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 248.16% — and 2025, when it sank 67.24%.
- Tracing WRBY's Depreciation & Amortization (CF) over 5 years: stood at $8.9 million in 2022, then rose by 16.29% to $10.4 million in 2023, then increased by 18.92% to $12.3 million in 2024, then grew by 6.24% to $13.1 million in 2025, then sank by 70.15% to $3.9 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $3.9 million (Q1 2026), $13.1 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 14.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.07 Mn |
| Jun 30, 2026 | 14.07 Mn |
| Mar 31, 2026 | 3.91 Mn |
| Mar 31, 2026 | 3.91 Mn |
| Dec 31, 2025 | 13.10 Mn |
| Dec 31, 2025 | 13.10 Mn |
| Sep 30, 2025 | 9.05 Mn |
| Sep 30, 2025 | 9.05 Mn |
| Jun 30, 2025 | 12.49 Mn |
| Jun 30, 2025 | 12.49 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 12.33 Mn |
| Dec 31, 2024 | 12.33 Mn |
| Sep 30, 2024 | 4.06 Mn |
| Sep 30, 2024 | 4.06 Mn |
| Jun 30, 2024 | 7.37 Mn |
| Jun 30, 2024 | 7.37 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Mar 31, 2024 | 10.58 Mn |